The analysis of the Oncomine database showed that HSPA6 is overexpressed in breast cancer, CNS, and brain malignancies, cervical cancer, kidney cancer, lymphoma and leukemia, and GC and colorectal cancer. Here, HSPA6 is linked to breast carcinoma.